id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-V-3371-0003,FDA,FDA-2022-V-3371,Variance Approval from FDA CDRH to Ralph Geronilla,Other,Approval for Variance (VRA),2023-01-03T05:00:00Z,2023,1,2023-01-03T05:00:00Z,,2023-01-03T15:38:15Z,,0,0,090000648557eb9b
FDA-2022-V-3371-0001,FDA,FDA-2022-V-3371,Variance Application from Ralph Geronilla,Other,Application for Variance (VAR),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T14:57:59Z,,0,0,090000648555c32c
FDA-2022-V-3371-0002,FDA,FDA-2022-V-3371,Acknowledgment Letter from FDA DMS to Ralph Geronilla,Other,Acknowledgement Letter/Receipt,2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T14:58:11Z,,0,0,090000648555c32f